Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04802356
What this trial is testing

Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 50
Large-scale testing (Phase 3)Ended earlyNCT02579863
What this trial is testing

Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC 310
Not applicableStudy completedNCT03001804
What this trial is testing

Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients

Who this might be right for
Multiple Myeloma
Celgene 29
Testing effectiveness (Phase 2)Ended earlyNCT00337506
What this trial is testing

Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nantes University Hospital 50
Large-scale testing (Phase 3)Looking for participantsNCT06932562
What this trial is testing

Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03742297
What this trial is testing

Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

Who this might be right for
Newly Diagnosed Multiple Myeloma
PETHEMA Foundation 462
Testing effectiveness (Phase 2)Study completedNCT00617591
What this trial is testing

Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 57
Testing effectiveness (Phase 2)Looking for participantsNCT06997081
What this trial is testing

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)

Who this might be right for
Multiple Myeloma
University of Miami 104
Testing effectiveness (Phase 2)WithdrawnNCT03608501
What this trial is testing

Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)Study completedNCT02405364
What this trial is testing

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Testing effectiveness (Phase 2)Looking for participantsNCT07085728
What this trial is testing

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

Who this might be right for
Myeloma Multiple
Eastern Cooperative Oncology Group 74
Testing effectiveness (Phase 2)UnknownNCT03669445
What this trial is testing

Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 45
Post-approval studies (Phase 4)Looking for participantsNCT06409702
What this trial is testing

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Who this might be right for
Newly DiagnosedHigh RiskMRD+1 more
The First Affiliated Hospital of Soochow University 59
Large-scale testing (Phase 3)Looking for participantsNCT04566328
What this trial is testing

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Who this might be right for
Plasma Cell MyelomaRISS Stage I Plasma Cell MyelomaRISS Stage II Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group 1,450
Not applicableStudy completedNCT00907452
What this trial is testing

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

Who this might be right for
Myeloma
Intergroupe Francophone du Myelome 143
Not applicableStudy completedNCT06095752
What this trial is testing

Multiple Myeloma Prognostic Indices

Who this might be right for
Multiple MyelomaHematologic Diseases
Assiut University 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07709884
What this trial is testing

A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen

Who this might be right for
Newly Diagnosed Multiple MyelomaT(11;14)Sotoclax+1 more
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05392946
What this trial is testing

Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study

Who this might be right for
Plasma Cell Myeloma
Mayo Clinic 49
Early research (Phase 1)Looking for participantsNCT07333261
What this trial is testing

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Susan Bal 25
Large-scale testing (Phase 3)Looking for participantsNCT06879379
What this trial is testing

KPD Consolidation After ASCT in NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Peking University People's Hospital 202
Next Page